"hmm...yahoo finance has 1 year estimate at $3... :("
It is impossible for any analysts to provide a positive estimate given there has not been a skerick of fundamentals released since the new listing...
...it is actually quite surprising that Plumb has not even sent a nice welcome letter to holders, let alone a welcome announcement that says he will be releasing a fundamentals update shortly.
All we have is the following from 14th November:
"Biota's move to the United States marks the beginning of a transformative period for the company. With two drugs on the market and a robust pipeline anchored by laninamivir, Biota represents a truly unique opportunity and I'm excited to play a role in maximizing the Company's potential," commented Russell H. Plumb, Biota Pharmaceuticals Chief Executive Officer.
and
"Russ and Joe are talented and proven executives who bring a successful track record of leading and operating drug development companies," said Jim Fox, Chairman of the Board of Directors of Biota. "I believe that the strong commercial skills exhibited by Russ and Joe will augment the excellent science of Biota and create a unique value proposition for our shareholders."
I would suggest that there will have to be updated info that must be released to the market, given that we are 8 weeks into the merger and nothing at all has even been whispered.
As CGT said, the upcoming JP Morgan conference will have to see some tidbits of new info.
BTA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
